BioHealth News Archive
SARS-CoV-2 Lurked for Decades Where Others Like It Lurk Still
Future pandemics—and suffering of the kind inflicted by COVID-19—could be avoided if we troubled ourselves to see where dangerous pathogens lie in wait. We…
Read More
Biotechnology draws $12.6B from private equity, venture capital activity in H1 | S&P Global Market Intelligence
Biotechnology led the healthcare industry in investment activity from private equity and venture capital during the first half of 2020, drawing nearly $12.60 billion…
Read MoreJohns Hopkins Receives $35M In Funding For COVID-19 Blood Plasma Trials – CBS Baltimore
BALTIMORE (WJZ) — Johns Hopkins researchers have received over $30 million in funding from the U.S. Department of Defense for two nationwide clinical trials to…
Read More
Innate Pharma announces publication of EXPLORE COVID-19 translational study findings in Nature | Innate Pharma
Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature paper entitled,…
Read More
Illumina Accelerator Grant Competition
Now Accepting Rolling Grant Applications The Illumina Accelerator Sequencing Grant Competition encourages entrepreneurs to build startups using next-generation sequencing. Awarded grant winners have the…
Read More
SHYCOCAN – A Device to Disable Coronaviruses – to be Marketed Under US-FDA’s Enforcement Discretion During the COVID-19 Public Health Emergency | BioSpace
GAITHERSBURG, Md., July 23, 2020 /PRNewswire/ -- Shreis Scalene Therapeutics LLC (SSTx), a MD-USA-based medical device company will fast-track the manufacture and distribution of…
Read More
TruGenomix just won Start Up of the Year Pitch Event
Excited to announce that TruGenomix just won Start Up of the Year Pitch Event. Great pitch Charles Cathlin !!!!! #SDVOB #ptsd #TruGenomix #veteranshelpingveterans
Read More
Emergent Bio inks deal with AstraZeneca for manufacture of COVID-19 vaccine (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (NYSE:EBS) has signed an agreement with AstraZeneca (NYSE:AZN) to provide contract development and manufacturing (CDMO) services for large-scale drug substance manufacturing for AZN's…
Read More
Undergraduate Scholarships
Each scholarship is a one-time award; however previous applicants and past scholarship recipients are eligible to re-apply. Full-time, part-time, online and distance learning programs…
Read More
AstraZeneca mines another $6B ADC from Daiichi Sankyo, with blockbuster ambitions to ‘redefine treatment standards’ – Endpoints News
Pascal Soriot isn’t letting the all-consuming R&D and manufacturing work on a Covid-19 vaccine slow down his hunt for AstraZeneca’s next blockbuster cancer drugs.…
Read More
Emergent BioSolutions Signs Agreement with AstraZeneca to Expand Manufacturing for COVID-19 Vaccine Candidate NYSE:EBS
GAITHERSBURG, Md., July 27, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has signed an agreement to provide contract development…
Read More
“COVID-19 edition” of pediatric medical device
WASHINGTON – (July 22, 2020) – The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces eight winners chosen in its special COVID-19 edition…
Read More
Sanford Health and TruGenomix announce partnership to commercialize genomic test for PTSD
SIOUX FALLS, S.D., July 23, 2020 /PRNewswire/ -- Sanford Health, the largest provider of rural healthcare in the country, today announced an $800,000 investment in…
Read More
Maryland VC funding defies dire pandemic predictions, rises in Q2 – Technical.ly Baltimore
When it comes to Maryland companies, the pandemic isn’t slowing down venture capital funding. Data from the latest MoneyTree report by PricewaterhouseCoopers/CB Insights shows…
Read More
Incoming international students must remain abroad despite visa rule reversal – The Johns Hopkins News-Letter
“Today, we feel forgotten. Everyone believes we still won. The class of 2024 didn’t win. After calls and emails, we’re met with another unyielding…
Read More